A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC).
Kim SH, Shim HS, Cho J, Jeong JH, Kim SM, Hong YK, Sung JH, Ha SJ, Kim HR, Chang H, Kim JH, Tania C, Cho BC.
Kim SH, et al. Among authors: shim hs.
Lung Cancer. 2013 Mar;79(3):270-5. doi: 10.1016/j.lungcan.2012.11.017. Epub 2012 Dec 20.
Lung Cancer. 2013.
PMID: 23261229
Clinical Trial.